Reliability, validity of the Vitiligo Extent Score | CCID
Figure 1 from Vitiligo Extent Tensity Index (VETI) score: a new definition, assessment and treatment evaluation criteria in vitiligo | Semantic Scholar
The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force - Taïeb - 2007 - Pigment Cell Research - Wiley Online Library
Cutting-Edge Developments in Vitiligo
Effect of Vitiligo Area Scoring Index on the quality of life in patients with vitiligo Hammam MA, Yasien HA, Algharably AF - Menoufia Med J
Deux essais randomisés montrent les effets du Ruxolitinib 1,5% crème dans le vitiligo
Jung Min Bae, MD, PhD Oral Abstract 2021 – Global Vitiligo Foundation
Opzelura (ruxolitinib) for the Treatment of Vitiligo, US
AbbVie Announces Upadacitinib Meets Primary Endpoint of Phase 2 Trial for Vitiligo - Advances to Phase 3 - LiVDerm
Vitiligo Area Scoring Index (VASI) of total skin and area specific, and... | Download Table
NEJM on X: "In two phase 3, double-blind, placebo-controlled trials, the Janus kinase inhibitor ruxolitinib showed superiority to vehicle control in facial repigmentation of vitiligo. https://t.co/zgkUMYHtIO https://t.co/gP3cgVCrtK" / X
The validity, reliability and acceptability of the SAVASI; a new self‐assessment score in vitiligo - Komen - 2015 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
Interview guide excerpt: F-VASI meaningful change illustrative graphic... | Download Scientific Diagram
The mean Vitiligo Area Scoring Index (VASI) score with standard error... | Download Scientific Diagram
Vitiligo Area Scoring Index (VASI) of total skin and area specific, and... | Download Table
Vitiligo Bordeaux : la recherche
Development and validation of the fingertip unit for assessing Facial Vitiligo Area Scoring Index - ScienceDirect
Scoring systems in dermatology - ppt download
Oral Ritlecitinib For Active Non-Segmental Vitiligo Treatment - MDNewsline
Measurement of Therapeutic Response Using the Vitiligo Area Scoring Index in People With Vitiligo: - YouTube
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial - The Lancet
Ruxolitinib 1.5% to be approved late 2021 to early 2022. Very promising results, especially on the face : r/Vitiligo
The mean Vitiligo Area Scoring Index (VASI) score with standard error... | Download Scientific Diagram
